Delivery Order SPE2DB24D2205-SPE2DB24FDWDL
- Not listed
- This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $18,986.58, is a firm fixed-price delivery order with an ultimate completion date of January 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not designated as a set-aside. Amerisourcebergen also holds a $999,999,999...
- This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $10,515.98, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order, with a firm fixed price pricing type, and an ultimate completion date of February 21, 2025. The contract does not have a set-aside designation, indicating...
- This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,784.18. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). The award, with a ceiling value of $8,480.89, was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG syringes to the Defense Logistics Agency (DLA). The award, valued at $10,274.43, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a delivery order contract with no set-aside designation. The contract has an ultimate completion date of October 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PEN ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $15,650.17 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024 and was awarded on October 16, 2024. No set-aside was used for this award. The contract is...
- This contract award is for delivery orders of COSENTYX SENSOREADY 150 MG PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $11,460.04. The contract is a firm-fixed-price delivery order contract with an ultimate completion date of January 13, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award is for the delivery of the pharmaceutical product "COSENTYX SENSOREADY 150 MG PENML" to the Defense Logistics Agency (DLA). The $5,283.56 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024, with a completion date of December 5, 2024. The contract is a delivery order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SENSOREADY 150 MG PENML pharmaceutical products. The contract has an ultimate completion date of March 29, 2024 and a ceiling value of $1,832.99. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver COSENTYX SENSOREADY 150 MG PENML. The $28,697.95 fixed-price delivery order was awarded by the Defense Logistics Agency, a defense agency, with a completion date of May 23, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDWDLDelivery Order
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical products to the federal government. The contract, valued at $18,939.97, is a delivery order with a firm fixed price and an ultimate completion date of June 28, 2024. It is not designated as a set-aside contract. Amerisourcebergen, through its Corporate Office division, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA to provide a broad range of pharmaceutical products and medical supplies to support the agency's mission of providing logistics and acquisition services to the U.S. Armed Forces.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 6/27/24 |